Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pudilan Keyanning mouthrinse is a Traditional Chinese Medicine (TCM)-based oral care product developed for the management of dental plaque and gingivitis. The formulation is derived from the Pudilan formula, which typically consists of four medicinal herbs: *Scutellaria baicalensis* (Huangqin), *Taraxacum mongolicum* (Pugongying), *Corydalis bungeana* (Kudiding), and *Isatis tinctoria* (Banlangen). These components provide a synergistic effect characterized by anti-inflammatory, antibacterial, and antioxidant properties. The mouthrinse is designed to reduce gingival inflammation and inhibit the formation of dental plaque by targeting oral pathogens and modulating the local inflammatory response. It has been evaluated in Phase 4 clinical trials, including studies sponsored by the Peking University School of Stomatology, to compare its efficacy and safety against standard chemical mouthwashes like chlorhexidine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pudilan Keyanning mouthrinse.